As seen in Figure 6, healthy donor and untreated CLL platelets stimulated with CRP-xl showed an increase in phospho-Tec that was significantly decreased in platelets from ibrutinib-treated patients. The gene discussed is CRP; the disease is B-cell chronic lymphocytic leukemia.